Evidence map›Paper›PMID 38675502›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection.

Andreia Palmeira, Emília Sousa, Aylin Köseler, Ramazan Sabirli, Tarık Gören, İbrahim Türkçüer, Özgür Kurt, Madalena M Pinto, M Helena Vasconcelos

Abstract readPublished Erratum
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Andreia PalmeiraLaboratory of Organic and Pharmaceutical Chemistry (LQOF), Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.ORCID 0000-0002-1391-2143
Emília SousaLaboratory of Organic and Pharmaceutical Chemistry (LQOF), Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.ORCID 0000-0002-5397-4672
Aylin KöselerDepartment of Biophysics, Pamukkale University Faculty of Medicine, 20190 Denizli, Turkey.ORCID 0000-0003-4832-0436
Ramazan SabirliDepartment of Emergency Medicine, Kafkas University Faculty of Medicine, 36000 Kars, Turkey.
Tarık GörenDepartment of Emergency Medicine, Pamukkale University Faculty of Medicine, 20190 Denizli, Turkey.
İbrahim TürkçüerDepartment of Emergency Medicine, Pamukkale University Faculty of Medicine, 20190 Denizli, Turkey.ORCID 0000-0001-8342-4615
Özgür KurtDepartment of Microbiology, Acibadem Mehmet Ali Aydinlar University School of Medicine, 34752 Istanbul, Turkey.ORCID 0000-0001-5575-588X
Madalena M PintoLaboratory of Organic and Pharmaceutical Chemistry (LQOF), Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.ORCID 0000-0002-4676-1409
M Helena VasconcelosInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-7801-4643

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There was an error in the original publication [...].

Identifiers

PMID38675502
PMCPMC11054617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.